SCHEMBL9505883

SCHEMBL9505883

CN(C)CCCN1C(=O)C(O)C(c2ccccc2)Sc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1S Q13698 4/20 0.54
CYP2D6 P10635 9/20 0.52
CYP1A2 P05177 8/20 0.52
TSHR P16473 5/20 0.52
KCNH2 Q12809 5/20 0.52
ADRA1A P35348 4/20 0.52
HTR1A P08908 4/20 0.52
DRD2 P14416 4/20 0.52
CYP2C19 P33261 4/20 0.52
SLC22A1 O15245 3/20 0.52
HRH2 P25021 3/20 0.52
SCN1A P35498 3/20 0.52
SCN2A Q99250 3/20 0.52
SCN3A Q9NY46 3/20 0.52
PRNP P04156 3/20 0.52
CHRM2 P08172 3/20 0.52
ADRA2A P08913 3/20 0.52
CHRM1 P11229 3/20 0.52
DRD1 P21728 3/20 0.52
SLC6A2 P23975 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9506823 0.93 CACNA1S (0.62) CACNA1SCYP2D6CYP1A2TSHRKCNH2
Hydrochloric Acid SCHEMBL9506849 0.91 CACNA1S (0.53) CACNA1SCYP2D6CYP1A2TSHRKCNH2
SCHEMBL10507327 0.90 CACNA1S (0.70) CACNA1SCYP2D6CYP1A2TSHRKCNH2
SCHEMBL10507332 0.90 CACNA1S (0.70) CACNA1SCYP2D6CYP1A2TSHRKCNH2
SCHEMBL10507320 0.90 CACNA1S (0.70) CACNA1SCYP2D6CYP1A2TSHRKCNH2
Hydrochloric Acid SCHEMBL9504066 0.89 CACNA1S (0.69) CACNA1SCYP2D6CYP1A2TSHRKCNH2
SCHEMBL10541270 0.85 CACNA1S (0.61) CACNA1SCYP2D6CYP1A2TSHRKCNH2
SCHEMBL5812395 0.85 CACNA1S (0.61) CACNA1SCYP2D6CYP1A2TSHRKCNH2
SCHEMBL12557671 0.85 CACNA1S (0.61) CACNA1SCYP2D6CYP1A2TSHRKCNH2
SCHEMBL11001652 0.85 CACNA1S (0.61) CACNA1SCYP2D6CYP1A2TSHRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279425-B1 USE OF BENZOTHIAZEPINE DERIVATIVES, IN PARTICULAR DILTIAZEM, IN THE MANUFACTURE OF MEDICAMENTS TO PROTECT LYMPHOCYTES GÖDECKE AKTIENGESELLSCHAFT (DE) 1993-08-04 EP disclosed
US-4861770-A Use of benzothiazepine derivatives as lymphocyte protectors GOEDECKE AKTIENGESELLSCHAFT (DE) 1989-08-29 US disclosed
EP-0279425-A2 Use of benzothiazepine derivatives, in particular diltiazem, in the manufacture of medicaments to protect lymphocytes GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-08-24 EP disclosed